Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 1,30€(−58,73%). Der Median liegt bei 1,30€(−58,73%).
Kaufen | 2 |
Halten | 4 |
Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
3 Marijuana Stocks That Could Give You A Profitable Portfolio
The progress of the cannabis industry has been a remarkable achievement. Now many knew this explosion of legal cannabis would happen in such a way. Legal cannabis across the globe is growing and spreading like wildfire. Even though marijuana stocks are not seeing the same success as companies investing in the public sector, it could be profitable down the line. Companies have been expanding operations and teaming with other entities to further meet consumer demands.» Mehr auf marijuanastocks.com
3 Marijuana Stocks To Watch For Long-Term Investors
As most marijuana stocks are trading at all-time lows some are troubled by how a successful industry can be doing poorly in the market. As the 2025 first-quarter earnings show, a bulk of the companies that reported showed solid results. This ranges from new products and partnerships to increased profits and revenue. In addition to company growth and shortcomings as well. Overall the cannabis industry has continued to blossom into what many felt would never happen.» Mehr auf marijuanastocks.com
June 2025 Watchlist: Best Ancillary Cannabis Stocks for Smart Investors
The U.S. cannabis industry continues to expand, even with ongoing regulatory challenges. In 2025, the market is projected to generate over $45 billion in revenue. Consumer demand is rising, and dispensary numbers continue to grow across the country. By 2030, the market could exceed $75 billion, driven by both medical and recreational use. So far, 24 states and Washington, D.C., have legalized recreational cannabis. In addition, 39 states allow it for medical purposes. However, federal prohibition still limits banking access and interstate commerce. Despite this, ancillary companies play a vital role. These firms do not touch the plant but support cultivation, production, and distribution. As the industry matures, these businesses offer more stability. For that reason, investors are closely watching key ancillary stocks this week.» Mehr auf marijuanastocks.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 37,47 Mio | 25,35% |
Bruttoeinkommen | 6,36 Mio | 39,10% |
Nettoeinkommen | −13,30 Mio | 13,82% |
EBITDA | −10,15 Mio | 1.738,88% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 14,35 Mio€ |
Anzahl Aktien | 4,64 Mio |
52 Wochen-Hoch/Tief | 7,42€ - 1,30€ |
Dividenden | Nein |
Beta | 2,4 |
KGV (PE Ratio) | −2,40 |
KGWV (PEG Ratio) | 0,04 |
KBV (PB Ratio) | 0,78 |
KUV (PS Ratio) | 0,09 |
Unternehmensprofil
Name | Hydrofarm Holdings Group Aktie |
CEO | B. John Lindeman |
Mitarbeiter | 286 |
Assets entdecken
Shareholder von Hydrofarm Holdings Group Aktie investieren auch in folgende Assets